Pet Imaging and its Application in Cardiovascular Diseases
By: Zheng Li, Anisha A. Gupte, Anjun Zhang and Dale J. Hamilton
References
- Borradaile NM Schaffer JE. Lipotoxicity in the heart. Curr Hypertens Rep. 2005 Dec; 7( 6): 412– 7.
- Dimmeler S. Cardiovascular disease review series. EMBO Mol Med. 2011 Dec; 3( 12): 697.
- Mensah GA Brown DW. An overview of cardiovascular disease burden in the United States. Health Aff (Millwood). 2007 Jan–Feb; 26( 1): 38– 48.
- Nabel EG. Cardiovascular disease. New Engl J Med. 2003 Jul 3; 349( 1): 60– 72.
- Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014 Jan–Feb; 56( 4): 369– 81.
- Mankoff DA. A definition of molecular imaging. J Nucl Med. 2007 Jun; 48( 6): 18N, 21N.
- Massoud TF Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003 Mar 1; 17( 5): 545– 80.
- Orosco RK, Tsien RY, Nguyen QT. Fluorescence imaging in surgery. IEEE Rev Biomed Eng. 2013; 6: 178– 87.
- Chuthapisith S, Eremin JM, Eremin O. Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review). Oncol Rep. 2008 Oct; 20( 4): 699– 703.
- Wong KK, Miller BS, Viglianti BL, Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review. Clin Nucl Med. 2016 Aug; 41( 8): e368– 82.
- Lindner JR Sinusas A. Molecular imaging in cardiovascular disease: Which methods, which diseases? J Nucl Cardiol. 2013 Dec; 20( 6): 990– 1001.
- Shaw SY. Molecular imaging in cardiovascular disease: targets and opportunities. Nat Rev Cardiol. 2009 Sep; 6( 9): 569– 79.
- Sogbein OO, Pelletier-Galarneau M, Schindler TH, Wei L, Wells RG, Ruddy TD. New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. BioMed Res Int. 2014; 2014: 942960.
- Strauss HW. Molecular and Multimodality Imaging in Cardiovascular Disease. J Nucl Med. 2016 Jul 1; 57( 7): 1158.
- Dorbala S, Di Carli MF, Beanlands RS, Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol. 2013 Jan 15; 61( 2): 176– 84.
- Kobylecka M, Maczewska J, Fronczewska-Wieniawska K, Mazurek T, Plazinska MT, Krolicki L. Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment). Nucl Med Rev Cent East Eur. 2012 Apr 24; 15( 1): 52– 60.
- Li Y, Zhang W, Wu H, Liu G. Advanced tracers in PET imaging of cardiovascular disease. Biomed Res Int. 2014; 2014: 504532.
- Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta. 2011 Jul; 1813( 7): 1333– 50.
- Amaral N Okonko DO. Metabolic abnormalities of the heart in type II diabetes. Diab Vasc Dis Res. 2015 Jul; 12( 4): 239– 48.
- Taegtmeyer H, Sen S, Vela D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann N Y Acad Sci. 2010 Feb; 1188: 191– 8.
- Kundu BK, Zhong M, Sen S, Davogustto G, Keller SR, Taegtmeyer H. Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis. Cardiology. 2015; 130( 4): 211– 20.
- Barger PM Kelly DP. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci. 1999 Jul; 318( 1): 36– 42.
- Hamirani YS, Kundu BK, McBride A, Noninvasive early detection of early metabolic left ventriculer remodeling in systemic hypertension. Cardiology. 2016; 133( 3): 157– 62.
- Li Y, Huang T, Zhang X, Determination of Fatty Acid Metabolism with Dynamic [11C]Palmitate Positron Emission Tomography of Mouse Heart In Vivo. Mol Imaging. 2015; 14: 516– 25.
- Lyons MR, Peterson LR, McGill JB, Impact of sex on the heart's metabolic and functional responses to diabetic therapies. Am J Physiol Heart Circ Physiol. 2013 Dec 1; 305( 11): H1584– 91.
- Rijzewijk LJ, van der Meer RW, Lamb HJ, Altered myocardial substrate metabolism and decreased diastolic function in non-ischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol. 2009 Oct 13; 54( 16): 1524– 32.
- Boudina S, Sena S, Theobald H, Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 2007 Oct; 56( 10): 2457– 66.
- Koves TR, Ussher JR, Noland RC, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008 Jan; 7( 1): 45– 56.
- Gupte AA Hamilton DJ. Molecular Imaging and Precision Medicine. Cardiology. 2016; 133( 3): 178– 80.
- Piquereau J, Caffin F, Novotova M, Mitochondrial dynamics in the adult cardiomyocytes: which roles for a highly specialized cell? Front Physiol. 2013 May 10; 4: 102.
- Huisman MC, Higuchi T, Reder S, Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med. 2008 Apr; 49( 4): 630– 6.
- Maddahi J, Czernin J, Lazewatsky J, Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med. 2011 Sep; 52( 9): 1490– 8.
- Berman DS, Maddahi J, Tamarappoo BK, Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol. 2013 Jan 29; 61( 4): 469– 77.
- Tsukada H, Nishiyama S, Fukumoto D, Kanazawa M, Harada N. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain. J Nucl Med. 2014 Mar; 55( 3): 473– 80.
- Yan X, Zhou Y, Liu S. Optical imaging of tumors with copper-labeled rhodamine derivatives by targeting mitochondria. Theranostics. 2012; 2( 10): 988– 98.
- Rubanyi GM. Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors. Mol Ther. 2013 Apr; 21( 4): 725– 38.
- Rodriguez-Porcel M, Cai W, Gheysens O, Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med. 2008 Apr; 49( 4): 667– 73.
- Gao H, Lang L, Guo N, PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2. Eur J Nucl Med Mol Imaging. 2012 Apr; 39( 4): 683– 92.
- Zhang H, Liu N, Gao S, Can an 18F-ALF-NOTA-PRGD2 PET/CT Scan Predict Treatment Sensitivity to Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma? J Nucl Med. 2016 Apr; 57( 4): 524– 9.
- Li F, Jiang S, Zu Y, Lee DY, Li Z. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor. J Nucl Med. 2014 Sep; 55( 9): 1525– 31.
- Wang W, Liu Z, Li Z. One-step (18)F labeling of non-peptidic bivalent integrin αVβ3 antagonist for cancer imaging. Bioconjug Chem. 2015 Jan 21; 26( 1): 24– 8.
- Gupte AA, Hamilton DJ, Cordero-Reyes AM, Mechanical unloading promotes myocardial energy recovery in human heart failure. Circulation Cardiovasc Genet. 2014 Jun; 7( 3): 266– 76.
- Cordero-Reyes AM, Gupte AA, Youker KA, Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function. J Mol Cell Cardiol. 2014 Mar; 68: 98– 105.
DOI: https://doi.org/10.14797/mdcj-13-1-29 | Journal eISSN: 1947-6108
Language: English
Page range: 29 - 33
Published on: Jan 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2017 Zheng Li, Anisha A. Gupte, Anjun Zhang, Dale J. Hamilton, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.